- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Frontotemporal Dementia
Authors
Keywords
Frontotemporal dementia, Primary progressive aphasia, Progressive supranuclear palsy, Corticobasal syndrome, Treatment, Memantine, Acetylcholinesterase inhibitor, Clinical trials, Therapeutics
Journal
Current Treatment Options in Neurology
Volume 16, Issue 11, Pages -
Publisher
Springer Nature
Online
2014-09-20
DOI
10.1007/s11940-014-0319-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Topiramate for Abnormal Eating Behaviour in Frontotemporal Dementia
- (2014) Colin Singam et al. BEHAVIOURAL NEUROLOGY
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
- (2014) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS
- (2014) Zhaoming Su et al. NEURON
- Pilot study of pharmacological treatment for frontotemporal dementia: Risk of donepezil treatment for behavioral and psychological symptoms
- (2013) Takemi Kimura et al. Geriatrics & Gerontology International
- Aripiprazole for Sexually Inappropriate Vocalizations in Frontotemporal Dementia
- (2013) Roy R. Reeves et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) Adam L Boxer et al. LANCET NEUROLOGY
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
- (2013) Christopher J. Donnelly et al. NEURON
- Managing abnormal eating behaviours in frontotemporal lobar degeneration patients with topiramate
- (2013) Shunichiro SHINAGAWA et al. Psychogeriatrics
- The Impact of Dementia Severity on Caregiver Burden in Frontotemporal Dementia and Alzheimer Disease
- (2012) Eneida Mioshi et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Frontotemporal Lobar Degeneration
- (2012) Rachel E. Seltman et al. CNS DRUGS
- Treatment of Indiscriminate, Inappropriate Sexual Behavior in Frontotemporal Dementia With Carbamazepine
- (2012) Connie E. Poetter et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Treatment implications of C9ORF72
- (2012) Sharon J Sha et al. Alzheimers Research & Therapy
- Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia
- (2011) Nathan Herrmann et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The effects of oxytocin on social cognition and behaviour in frontotemporal dementia
- (2011) Sarah Jesso et al. BRAIN
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Reversal of abnormal eating and drinking behaviour in a frontotemporal lobar degeneration patient using low-dose topiramate: Table 1
- (2011) Peter J Nestor JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Chronic divalproex sodium use and brain atrophy in Alzheimer disease
- (2011) A. S. Fleisher et al. NEUROLOGY
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
- (2011) Alan E. Renton et al. NEURON
- Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis
- (2010) Iuga Liepelt et al. Alzheimers & Dementia
- Neuropathology of variants of progressive supranuclear palsy
- (2010) Dennis W Dickson et al. CURRENT OPINION IN NEUROLOGY
- Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family
- (2010) A. L. Boxer et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
- (2009) Ian R. A. Mackenzie et al. ACTA NEUROPATHOLOGICA
- An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration
- (2009) Adam L. Boxer et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Stimulant Treatment of Frontotemporal Dementia in 8 Patients
- (2009) Edward D. Huey et al. JOURNAL OF CLINICAL PSYCHIATRY
- Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertraline
- (2009) C I Prodan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Topiramate may Modulate Alcohol Abuse But not Other Compulsive Behaviors in Frontotemporal Dementia
- (2008) Marcelo Cruz et al. Cognitive and Behavioral Neurology
- Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia
- (2008) A. Kertesz et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A 6‐month, open‐label study of memantine in patients with frontotemporal dementia
- (2008) Janine Diehl‐Schmid et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started